Ignite Creation Date:
2024-07-17 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497530
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
Sponsor:
Guangzhou Institute of Respiratory Disease
Organization:
Guangzhou Institute of Respiratory Disease
Organization Data
Organization:
Guangzhou Institute of Respiratory Disease
Class:
OTHER
Study ID:
CROC-24-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangzhou Institute of Respiratory Disease
Lead Sponsor Class:
OTHER
Responsible Party:
Zhou Chengzhi
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Guangzhou Institute of Respiratory Disease
Old Name:
None
Old Organization:
None